Nanocages di ferritina per il delivery di agenti antitumorali in carcinomi mammari primari ed in metastasi cerebrali

Project

Overview

Contributors

MAZZUCCHELLI SERENA   Scientific Manager  

Departments involved

Type

CAR_RIC - Bandi Fondazione Cariplo

Funder

FONDAZIONE CARIPLO
External Organization Funding Organization

Date/time interval

October 1, 2016 - April 30, 2018

Project duration

19 months

Publications

Outputs (2)

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 
SCIENTIFIC REPORTS
NATURE RESEARCH
2020
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines 
PHARMACEUTICS
MDPI
2019
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"